自发性震颤市场报告：2031 年趋势、预测与竞争分析

全球自发性震颤市场前景光明，医院、门诊手术中心以及诊断和专科诊所市场都蕴藏着巨大的机会。预计2025年至2031年，全球自发性震颤市场将以5.3%的复合年增长率成长。该市场的主要驱动力包括自发性震颤的上升、认知度的提高和早期诊断的提升，以及治疗方案的增加。

• Lucintel 预测，根据适应症，上肢将在预测期内经历最高的增长。
• 根据最终用途，预计医院将实现最高成长。
• 根据地区，预计北美将在预测期内实现最高成长。

自发性震颤市场的新趋势

自发性震颤市场瞬息万变，许多新兴趋势正在定义其未来发展方向。这些趋势表明，市场对更有效的治疗方法、更便捷的患者可及性以及有效管理自发性震颤的创新解决方案的需求日益增长。

• 外科治疗的技术进步：深部脑部刺激 (DBS) 和聚焦超音波技术正在改变自发性震颤的治疗。 DBS 的进展改善了患者的益处，并以微创的方式提供长期症状缓解。聚焦超音波正变得越来越流行，因为它是一种微创技术，无需手术即可针对引起震颤的脑区进行治疗。这些技术改善了患者的生活，并有望成为更受欢迎的治疗方法。
• 药物研发：药物领域的新进展，包括针对震颤症状的特异性标靶药物的核准，促进了自发性震颤市场的发展。先前只能透过仿单标示外途径取得的药物，如今已​​可用于处方，改善了特发性震颤患者的症状控制。近期的治疗方法旨在透过提供更具针对性的治疗方法来减少副作用并改善患者预后。随着研究的进展，在特发性震颤背后的机制研究方面可能会取得进一步的突破。
• 重视非侵入性治疗：针对自发性震颤的非侵入性治疗，例如聚焦超音波治疗和经颅磁刺激 (TMS)，正日益普及。这些治疗是传统外科手术治疗（包括深部脑电刺激 (DBS)）的微创治疗方法，并且因其恢復时间更短、併发症更少而广受欢迎。随着这些非侵入性治疗获得临床检验，它们很可能在特发性震颤的治疗中发挥重要作用。
• 以病人为中心的医疗模式：以病人为中心的医疗模式是自发性震颤市场的关键趋势。此模式着重于个人化治疗方案，旨在满足每位患者的特定需求。透过包括物理治疗、咨询和生活方式调整在内的整体管理，该模式旨在提升患者的整体健康水平。随着越来越多的人意识到以患者为中心的医疗模式的重要性，预计该模式将改善治疗效果并提升患者满意度。
• 远距监控与远端医疗：远端医疗和远距监控技术的发展正在彻底改变自发性震颤的治疗。远端医疗使患者和专家能够进行远距会诊，从而改善医疗资源匮乏人群的治疗可近性。远端监控设备还能即时追踪症状，使临床医师能够相应地调整治疗方案。这些技术有可能提高患者参与度并简化治疗方法，尤其适用于医疗资源有限的弱势群体。

这些新兴趋势正以更有效、更经济、更方便患者的治疗方法改变自发性震颤市场。科技、药物和患者照护的进步正在刺激成长，而非侵入性介入和远端医疗则正在改善治疗的可及性。随着这些趋势的持续，自发性震颤的治疗将持续改进，全球患者照护也将提升。

自发性震颤市场的最新趋势

自发性震颤市场的最新发展表明，人们对成功治疗和改善疾病控制的兴趣日益浓厚。以下是影响市场的五大主要发展趋势：

• 新药核准：新药的核准为自发性震颤的治疗带来了新的药物。这些药物旨在提供更有针对性的症状缓解，并减少副作用。这些新药的出现，以及旧药的不断发展，正在改善特发性震颤患者的整体治疗前景。
• 外科手术的进展：深部脑部刺激 (DBS) 在技术和疗效方面均取得了显着进展，为患有严重震颤的患者提供了持久的缓解。聚焦超音波等非手术干预措施也已作为 DBS 的替代方案推出，使患者能够选择在不进行手术的情况下治疗震颤。
• 放大聚焦超音波和经颅磁刺激 (TMS) 等非侵入性治疗正日益流行，因为它们能够以比手术更小的创伤性程度减轻震颤。对于不愿接受侵入性手术或有手术禁忌症的患者来说，此类治疗尤其具有吸引力。
• 远端医疗的成长机会：远端医疗已成为自发性震颤市场的重大技术创新，尤其是在新冠疫情期间。远端医疗使患者能够远端联繫专家，从而方便居住在偏远地区的患者接受诊断和治疗。远端医疗平台的扩展预计将持续成为一种经济实惠且省时的患者管理方案。
• 提高意识和教育宣传活动：自发性震颤的提高意识和教育倡议正在促进早期诊断和治疗。认识的提高使更多患者在疾病早期接受治疗，从而改善了长期疗效。此类宣传活动也减少了耻辱感，并确保了特发性震颤患者得到适当的治疗。

这些进展推动了自发性震颤市场的发展，推动了新治疗方法的开发、治疗管道的扩展以及人们对该疾病的认知度的提高。随着市场的成长，这些创新将改善全球自发性震颤患者的治疗效果和生活品质。

目录

第一章执行摘要

第二章全球自发性震颤市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球自发性震颤市场趋势（2019-2024 年）及预测（2025-2031 年）
• 按适应症
  • 头
  • 身体躯干
  • 上肢
  • 下肢
• 全球自发性震颤市场（依最终用途）
  • 医院
  • 门诊手术中心
  • 诊断和专科诊所

第四章2019年至2031年区域市场趋势与预测分析

• 按地区
• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按适应症
  • 按最终用途
  • 按地区
• 全球自发性震颤市场的新趋势
• 战略分析
  • 新产品开发
  • 扩大全球自发性震颤市场容量
  • 全球自发性震颤市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业简介

• InSightec's
• Merz Pharma
• Neurocrine Biosciences
• Sage Therapeutics

The future of the global essential tremor market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic & specialty clinic markets. The global essential tremor market is expected to grow with a CAGR of 5.3% from 2025 to 2031. The major drivers for this market are the rising prevalence of essential tremor, the growing awareness and early diagnosis, and the increasing availability of treatment options.

• Lucintel forecasts that, within the indication category, upper extremity is expected to witness the highest growth over the forecast period.
• Within the end use category, hospital is expected to witness the highest growth.
• In terms of region, North America is expected to witness the highest growth over the forecast period.

Emerging Trends in the Essential Tremor Market

The essential tremor market is changing fast, with a number of emerging trends defining its future. These trends indicate the increasing need for more effective treatments, enhanced patient access, and the continuous quest for innovative solutions to effectively manage Essential Tremor.

• Technological Advancements in Surgical Treatments: Deep brain stimulation (DBS) and focused ultrasound technologies are transforming the treatment of Essential Tremor. DBS has been advanced to enhance patient benefits with less invasive methods, providing long-term symptom reduction. Focused ultrasound, a minimally invasive technique, is increasing popularity because it can target brain regions responsible for producing tremors without surgery. These technologies are enhancing the lives of patients and will likely increase in popularity as a treatment.
• Pharmaceutical Developments: The market for Essential Tremor is being enhanced by new developments in pharmaceuticals, such as the approval of medicines with specific targets for tremor symptoms. Medicines previously only available off-label are increasingly being prescribed, enhancing symptom control for patients with ET. More recent treatments seek to offer more tailored strategies, decreasing side effects and enhancing outcomes for the patients. With advancing research, there are likely to be additional breakthroughs that address the mechanisms behind ET.
• Greater Emphasis on Non-Invasive Treatments: Non-invasive treatment of Essential Tremor is becoming increasingly popular, including focused ultrasound therapy and transcranial magnetic stimulation (TMS). These treatments provide patients with a less invasive alternative to the conventional surgical treatments, including DBS, and are popular because they have shorter recovery times and fewer complications. As these non-invasive treatments become more clinically validated, they will become important in the management of ET.
• Patient-Centered Care Models: Patient-centered care is a significant trend in the essential tremor market. This model focuses on individualized treatment plans that are customized to suit individual patient requirements. With holistic management, such as physical therapy, counseling, and lifestyle modification, this trend seeks to enhance overall patient well-being. As more people become aware of the significance of patient-centered care, we can expect improved outcomes and patient satisfaction.
• Remote Monitoring and Telemedicine: Growth in telemedicine and remote monitoring is revolutionizing the treatment of Essential Tremor. Telemedicine enables remote consultations between patients and specialists, enhancing the accessibility of care for underserved populations. Remote monitoring devices also facilitate real-time tracking of symptoms, enabling clinicians to modify treatments accordingly. These technologies have the potential to enhance patient engagement and simplify treatment regimens, particularly in underserved populations with limited access to healthcare facilities.

These new trends are transforming the essential tremor market with more efficient, affordable, and patient-friendly treatment methods. Advances in technologies, drugs, and patient care are stimulating growth, and non-invasive interventions and telemedicine are enhancing access. As these trends continue to unfold, treatment for Essential Tremor will become increasingly better, and patient care worldwide is likely to increase.

Recent Developments in the Essential Tremor Market

Current developments in the essential tremor market are an indicator of increasing interest in successful treatments and improved control of the condition. Five key developments influencing the market.

• Approval of New Pharmaceutical Treatments: New drug approvals have brought new pharmacological agents to the treatment of Essential Tremor. These drugs are designed to offer more targeted relief from symptoms with fewer side effects. The presence of these new drugs, along with the continued evolution of older drugs, is improving the overall treatment environment for ET patients.
• Progress in Surgical Interventions: Deep brain stimulation (DBS) has experienced notable technique and effectiveness advancements, delivering permanent relief for those suffering from intense tremors. Also, non-surgical interventions such as focused ultrasound are being introduced as options to DBS, providing patients with the alternative of treating tremors without going under the knife.
• Expansion of Non-Invasive Therapies: Non-invasive treatments such as focused ultrasound and transcranial magnetic stimulation (TMS) are increasing in popularity since they can alleviate tremors with minimal invasiveness, compared to surgery. Such treatments are particularly attractive for patients who would rather not have invasive procedures performed or who possess contraindications to undergoing surgery.
• Growth in Telemedicine Opportunities: Telemedicine has emerged as the major innovation in the essential tremor market, particularly during the COVID-19 pandemic. Telemedicine enables patients to access specialists remotely, thereby providing those residing in remote locations with greater access to diagnosis and treatment. The expansion of telemedicine platforms is anticipated to be sustained as an economical and time-saving option for patient management.
• Increasing Awareness and Educational Campaigns: Greater recognition of Essential Tremor, together with educational initiatives, is promoting early diagnosis and treatment. Greater awareness is increasing the number of patients who present for treatment earlier in the course of their disease, resulting in improved long-term outcomes. Such campaigns are also reducing stigma and ensuring ET patients receive appropriate treatment.

These advances are pushing the essential tremor market ahead by developing new treatments, broadening access to treatment, and creating greater awareness of the disease. As the market grows, these innovations will enhance outcomes and quality of life for patients with Essential Tremor around the world.

Strategic Growth Opportunities in the Essential Tremor Market

The essential tremor market offers a number of strategic growth opportunities in key applications such as pharmaceuticals, medical devices, and patient care. The following are five major growth opportunities for the market.

• Pharmaceutical Innovation: There is great room for expansion in the creation of new drugs for Essential Tremor. Targeted therapies, designed to treat the root causes of tremor, will fuel market expansion. Furthermore, ongoing optimization of current medications to minimize side effects and maximize efficacy offer pharmaceutical firms the ability to improve their products in the ET market.
• Non-Invasive Therapies: Increased need for non-invasive treatments, including focused ultrasound and transcranial magnetic stimulation (TMS), creates a great opportunity for businesses to innovate and offer more treatment possibilities for Essential Tremor. These treatments are increasing in popularity as they can provide relief from tremors without resorting to invasive surgery, offering patients an appealing alternative with fewer risks.
• Telemedicine and Remote Monitoring: The infusion of telemedicine and remote monitoring technology into treatment of Essential Tremor presents one of the strongest opportunities for growth. These platforms give patients symptom management on a daily basis, allowing healthcare practitioners to adjust care in real-time. Telemedicine adoption across healthcare markets is also extremely valuable within underserved populations, enhancing accessibility of care to those who could otherwise have no care at all.
• Patient Education and Awareness Programs: Greater emphasis on patient education and awareness offers a market growth opportunity. As individuals become increasingly informed about Essential Tremor, they are more apt to seek early treatment and engage in treatment alternatives. Businesses can take advantage of this trend by funding educational efforts, developing tools for patients and physicians, and encouraging early diagnosis.
• Enhanced Access to Advanced Treatments: Increased availability of advanced therapy like DBS and focused ultrasound therapy is an opportunity for growth in the market for Essential Tremor. With improving healthcare systems in developing nations, these therapies will become more available to more people, fueling international market growth.

The essential tremor market holds huge growth opportunities in a number of key sectors, such as pharmaceutical innovation, non-invasive treatments, telemedicine, and patient education. With these opportunities being pursued and built upon, the market is projected to increase, enhancing the quality of treatment and access to treatment for patients suffering from Essential Tremor across the globe.

Essential Tremor Market Driver and Challenges

The essential tremor market is influenced by several drivers and challenges, such as technological innovations, economic factors, and regulatory factors. Knowing these factors is important in order to navigate the changing environment of the market. The following are five drivers and three challenges that are shaping the market.

The factors responsible for driving the essential tremor market include:

1. Increasing Incidence of Essential Tremor: With an aging global population, the prevalence of Essential Tremor is growing, fueling demand for treatments that work. Increasing numbers are looking for diagnosis and treatment, and healthcare systems are enlarging to accommodate. Growing incidence is a primary market driver.

2. Treatment Advances: Improvements in the availability of technological advances such as new drugs, deep brain stimulation (DBS), and other non-invasive treatments such as focused ultrasound are fueling the growth of the market. They provide better treatment outcomes for patients and are gaining wider acceptance

3. Increasing Awareness and Diagnosis: Growing awareness of Essential Tremor is resulting in earlier diagnosis and improved patient outcomes. With continuing awareness campaigns, more individuals are coming forward for treatment at an earlier stage, fueling market growth.

4. Enhanced Access to Healthcare: The development of healthcare infrastructure, especially in emerging countries, is enhancing access to treatment for Essential Tremor. As healthcare becomes more accessible, more patients are being diagnosed and treated, which is fueling market growth.

5. Patient-Centered Care: Patient-centered care is on the rise, with tailored treatment plans based on individual needs. It is increasing patient outcomes and adherence to treatment, which is augmenting market growth.

Challenges in the essential tremor market are:

1. High Cost of Treatment: New treatments for Essential Tremor, like DBS and focused ultrasound, are costly, restricting their availability in some areas. The cost of treatment is a major obstacle for most patients, especially in the developing world.

2. Limited Awareness in Certain Areas: Although awareness of Essential Tremor is increasing, certain areas remain unaware of the condition. This leads to delayed diagnosis and treatment, which can have adverse effects on patient outcomes.

3. Regulatory Barriers: Regulatory barriers can slow down the approval and availability of new therapies. Stringent regulatory procedures, particularly in developing markets, can hinder market growth and restrict the availability of innovative treatments.

The essential tremor market is fueled by growing incidence of the condition, increasing treatment options, and rising patient awareness. Nonetheless, high treatment costs, poor awareness in certain geographies, and regulatory issues are major restraints. Insight into these drivers and challenges is critical to traversing the shifting landscape of the market and driving further growth.

List of Essential Tremor Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies essential tremor companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the essential tremor companies profiled in this report include-

• InSightec's
• Merz Pharma
• Neurocrine Biosciences
• Sage Therapeutics

Essential Tremor Market by Segment

The study includes a forecast for the global essential tremor market by indication, end use, and region.

Essential Tremor Market by Indication [Value from 2019 to 2031]:

• Head
• Trunk
• Upper Extremity
• Lower Extremity

Essential Tremor Market by End Use [Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Center
• Diagnostic & Specialty Clinics

Essential Tremor Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Essential Tremor Market

The essential tremor market has seen some remarkable developments over the past few years, especially in terms of treatment avenues and access to healthcare. Essential Tremor (ET) is a very prevalent movement disorder, striking millions across the globe, and research and advancements undertaken in recent times have dramatically changed patient care for the better. Advances in pharmaceuticals, surgical procedures, and medical devices have made a huge difference in the management of this disorder. With a growing aging population and greater awareness, the demand for effective treatments is rising. In this context, we explore the recent developments in the essential tremor market across the United States, China, Germany, India, and Japan.

• United States: The essential tremor market in the United States is experiencing notable growth due to the increasing prevalence of the disorder and the expanding range of available treatments. Pharmaceutical advances, such as the approval of new drugs such as anaplastic thyroid cancer (ATC) inhibitors, have allowed for improved symptom control. Furthermore, advances in deep brain stimulation (DBS) and other surgical treatments have greatly enhanced outcomes for those with extreme tremor. The U.S. marketplace also has a well-established medical system in place, providing access to such advancements. Yet, there are challenges such as high treatment prices and continued research into more individualized treatments.
• China: In China, the market for Essential Tremor is growing as the population of the country ages, causing an increase in the incidence of neurological conditions like ET. The government's increasing emphasis on healthcare reform has enhanced access to diagnosis and treatment, especially in urban centers. Pharmaceutical interventions and DBS operations have become popular, but rural regions still lack access to these interventions. China's market for pharmaceuticals is also becoming increasingly competitive with the increased popularity of generic alternatives, which create affordable solutions for ET patients. There is more that can be done, however, despite this advancement, in the way of more inclusive healthcare policy to make treatments more accessible to the masses.
• Germany: Germany boasts one of the world's most advanced healthcare systems, and this is evident in how Essential Tremor is treated. Developments in pharmaceuticals and medical devices have enhanced the patient's quality of life for those afflicted with ET. Most significant among these advances has been the application of botulinum toxin injections and further development of DBS procedures. Germany's medical infrastructure provides patients with access to state-of-the-art technology and treatments. Still, some of the high prices of treatments and lengthy wait times for specialist visits in some regions continue to pose challenges. The market also is changing with heightened patient awareness and new clinical trials in process.
• India: India is witnessing greater awareness and accessibility of Essential Tremor, encouraged by a mounting population of the elderly as well as better healthcare access. Generic forms of largely prescribed drugs became available, helping ET treatment prices become more budget-friendly. Even so, access to sophisticated interventions such as DBS remains sparse in the entire country, but especially so outside major urban agglomerations in rural settings. There is also increasing demand for alternate forms of therapy, including physical therapy and herbal remedies, although these are still not conventional in ET treatment. India stands to witness further development in the ET market due to enhanced access to healthcare as well as publicity drives.
• Japan: There is a well-established health system in Japan that affords good access to diagnosis and treatment of Essential Tremor. Over the past few years, there has been a trend towards minimally invasive therapies like focused ultrasound therapy and newer DBS methods, which have helped improve outcomes. The increasing incidence of ET in the aging Japanese population has also fueled demand for treatment. Japan is also witnessing the introduction of newer pharmacological treatments for tremor control. Nevertheless, Japan is an important country in the global market of Essential Tremor. There are, however, difficulties to ensure equal treatment access throughout the country, particularly in rural locations.

Features of the Global Essential Tremor Market

Market Size Estimates: Essential tremor market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Essential tremor market size by indication, end use, and region in terms of value ($B).

Regional Analysis: Essential tremor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different indication, end use, and regions for the essential tremor market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the essential tremor market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the essential tremor market by indication (head, trunk, upper extremity, and lower extremity), end use (hospitals, ambulatory surgical center, and diagnostic & specialty clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Essential Tremor Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Essential Tremor Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Essential Tremor Market by Indication
  • 3.3.1: Head
  • 3.3.2: Trunk
  • 3.3.3: Upper Extremity
  • 3.3.4: Lower Extremity
• 3.4: Global Essential Tremor Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Ambulatory Surgical Center
  • 3.4.3: Diagnostic & Specialty Clinics

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Essential Tremor Market by Region
• 4.2: North American Essential Tremor Market
  • 4.2.1: North American Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics
• 4.3: European Essential Tremor Market
  • 4.3.1: European Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics
• 4.4: APAC Essential Tremor Market
  • 4.4.1: APAC Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics
• 4.5: ROW Essential Tremor Market
  • 4.5.1: ROW Market by Indication: Head, Trunk, Upper Extremity, and Lower Extremity
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Center, and Diagnostic & Specialty Clinics

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Essential Tremor Market by Indication
  • 6.1.2: Growth Opportunities for the Global Essential Tremor Market by End Use
  • 6.1.3: Growth Opportunities for the Global Essential Tremor Market by Region
• 6.2: Emerging Trends in the Global Essential Tremor Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Essential Tremor Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Essential Tremor Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: InSightec's
• 7.2: Merz Pharma
• 7.3: Neurocrine Biosciences
• 7.4: Sage Therapeutics